Novartis Patient Assistance Foundation, Inc. (NPAF)
Run by Novartis Pharmaceuticals Corporation
Novartis Patient Assistance Foundation, Inc. (NPAF), run by Novartis Pharmaceuticals Corporation, provides the medication at no cost if you qualify. One eligibility path: "You don't have insurance."
At a glance
- Run by
- Novartis Pharmaceuticals Corporation
- Status
- Verified
- Last verified
- 08/18/26
- Medicare
- No confirmed Medicare eligibility path for this program.
- Confirmed medications
- 1
- Coverage unconfirmed
- 28
Phone 1-800-277-2254
Income limits and eligibility paths
Review each published path and its conditions. A path may apply only to certain medications or insurance coverage.
You don't have insurance
The program states that you must meet its income guidelines, and that Alaska and Hawaii have different income limits, but it does not publish the dollar figures. They are shown in its own Check Your Eligibility tool.
Income basis
Published household amounts
Confirm the table’s geographic applicability and larger-household rules with the program.
You have Medicare or other government insurance
Same undisclosed income guideline structure as the no-insurance track.
Income basis
Published household amounts
Confirm the table’s geographic applicability and larger-household rules with the program.
Insurance and other requirements
Each path has its own conditions. Read the complete requirements and confirm which path applies to you.
-
Path 1
You don't have insurance
Insurance category: no-insurance
- ·The program states that you must meet its income guidelines, and that Alaska and Hawaii have different income limits, but it does not publish the dollar figures. They are shown in its own Check Your Eligibility tool.
- ·Anti-alternative-funding clause: NPAF does not provide product to individuals whose insurance is associated with an alternate funding program that conditions/restricts/adjusts coverage based on application to NPAF or any other free-goods program.
- ·Eligible patients are described as uninsured or government-insured; a separate underinsured/partial-coverage path is not currently published.
-
Path 2
You have Medicare or other government insurance
Insurance category: government-other
- ·Same undisclosed income guideline structure as the no-insurance track.
- ·Subject to proof of income and evidence of Medicare Extra Help (LIS) denial 'as deemed necessary.'
What this program covers
1 confirmed covered, 54 documented exclusions and 28 unconfirmed associations. Check the category before relying on a medication link.
Covered medications
- Coartem tablet Covered · 08/20/26
Confirmed covered associations. The program’s eligibility rules still apply.
Not on this program's current list
- Afinitor Not covered · 08/19/26
- Arranon Not covered · 08/19/26
- Betoptic S Not covered · 08/19/26
- Desferal Not covered · 08/19/26
- Diovan Not covered · 08/19/26
- Diovan HCT Not covered · 08/19/26
- Egaten Not covered · 08/19/26
- Entresto Not covered · 08/19/26
- Exelon Not covered · 08/19/26
- Exforge Not covered · 08/19/26
- Exforge HCT Not covered · 08/19/26
- Exjade Not covered · 08/19/26
- Femara Not covered · 08/19/26
- Focalin Not covered · 08/19/26
- Gleevec Not covered · 08/19/26
- Hycamtin Not covered · 08/19/26
- Ilevro Not covered · 08/19/26
- Itvisma Not covered · 08/19/26
- Kymriah Not covered · 08/19/26
- Lotrel Not covered · 08/19/26
- Maxitrol Not covered · 08/19/26
- Myfortic Not covered · 08/19/26
- Promacta Not covered · 08/19/26
- Ritalin Not covered · 08/19/26
- Sandostatin Not covered · 08/19/26
- Simulect Not covered · 08/19/26
- Danziten Not covered · 08/19/26
- Tobradex Not covered · 08/19/26
- Travatan Not covered · 08/19/26
- Triesence Not covered · 08/19/26
- GENGRAF Capsules Not covered · 08/19/26
- Purixan Not covered · 08/19/26
- CARBATROL Not covered · 08/19/26
- Tobi Products Not covered · 08/19/26
- Oxtellar XR Not covered · 08/19/26
- Arcapta Neohaler powder; inhalation Not covered · 08/20/26
- Entresto tablet Not covered · 08/20/26
- Focalin XR capsule; extended release Not covered · 08/20/26
- Glatopa injection Not covered · 08/20/26
- Lamisil granule; oral Not covered · 08/20/26
- Myfortic tablet; delayed release Not covered · 08/20/26
- Neoral Not covered · 08/20/26
- Omnitrope injection Not covered · 08/20/26
- Reclast injectable; iv (infusion) Not covered · 08/20/26
- Sandimmune Not covered · 08/20/26
- Tegretol XR tablet; extended release Not covered · 08/20/26
- Tekturna HCT tablet Not covered · 08/20/26
- Tekturna tablet Not covered · 08/20/26
- Tobi Podhaler powder; inhalation Not covered · 08/20/26
- Tobi solution; inhalation Not covered · 08/20/26
- Trileptal tablet Not covered · 08/20/26
- Tyzeka tablet Not covered · 08/20/26
- Zortress tablet Not covered · 08/20/26
- Lotensin Not covered · 08/20/26
These exclusions refer to this program only. They do not prove that all other help is unavailable.
Coverage unconfirmed
- Adakveo Unknown
- Afinitor Disperz Unknown
- Beovu Unknown
- Coartem Unknown
- Cosentyx Unknown
- Fabhalta Unknown
- Gilenya Unknown
- Ilaris Unknown
- Jadenu Sprinkle Unknown
- Kesimpta Unknown
- Kisqali Unknown
- Leqvio Unknown
- Lutathera Unknown
- Mayzent Unknown
- Mekinist Unknown
- Piqray Unknown
- Pluvicto Unknown
- Rhapsido Unknown
- Rydapt Unknown
- Sandostatin LAR Depot Unknown
- Scemblix Unknown
- Tabrecta Unknown
- Tafinlar Unknown
- Tykerb Unknown
- Vanrafia Unknown
- Vijoice Unknown
- Votrient Unknown
- Zykadia Unknown
Our records link these medications to this program, but we do not have enough evidence to confirm coverage. Contact the program before relying on this association.
How to apply
Continue to the official program website ↗
Use the program’s official application. Required documents, approval periods and renewal rules vary.
Keep your approval notice. It explains when assistance ends and what to do if renewal is required.
-
1
Check the official application
Confirm medication coverage and the eligibility path that fits your situation.
-
2
Gather the required documents
Use the income and insurance documents requested by the current form.
-
3
Coordinate with your prescriber
Ask whether clinical information, a prescription or a signature is required.
-
4
Submit and follow up
Confirm receipt and ask about the decision, approval period and renewal rules.
If this is more than you want to take on
Help with the application paperwork
You can follow the official application instructions yourself. If you choose paid help, ask which documents and follow-up tasks the fee includes.
Compare current pricing, cancellation terms and available reviews. Paying for paperwork does not establish eligibility or guarantee approval.
- Ask which forms the service prepares and submits
- Ask how the service works with your prescriber
- Check whether renewal assistance is included
Paid paperwork help is optional. Confirm the official program’s requirements first.
What changed
Changes to this program’s rules, from newest to oldest, based on its published information.
07/27/26 Beginning 07/27/26, NPAF introduced a new online Patient Enrollment Portal for patients who applied for NPAF support on or after that date. Approved patients use it to refill medication; patients with missing documentation use it to upload documents.
Documents we track
Program document
Available on the program’s official website, last checked 08/18/26. Confirm current requirements at: https://pap.novartis.com/.
This link points to the program’s own document. Check the record’s verification status and confirm current terms.
What changed on this record
Novartis Patient Assistance Foundation, Inc. (NPAF) requirements read and verified; tracking began.
Beginning 07/27/26, NPAF introduced a new online Patient Enrollment Portal for patients who applied for NPAF support on or after that date. Approved patients use it to refill medication; patients with missing documentation use it to upload documents.